What’s new about angiotensin receptor blocker (ARB) therapy for Marfan syndrome: A narrative review
Published online on February 03, 2026
Abstract
Vascular Medicine, Volume 31, Issue 2, Page 219-231, April 2026.
Marfan syndrome (MFS) is a genetic disorder caused by mutations in theFBN1gene, which encodes fibrillin-1, a crucial protein involved in the structure of elastic fibers and the regulation of transforming growth factor-beta (TGF-β) bioavailability. ...
Marfan syndrome (MFS) is a genetic disorder caused by mutations in theFBN1gene, which encodes fibrillin-1, a crucial protein involved in the structure of elastic fibers and the regulation of transforming growth factor-beta (TGF-β) bioavailability. ...